Alexandra Stefanovic, MD

Associate Professor of Medicine
Campus mail Box 3961 Med Ctr, Durham, NC 27710
Phone (919) 668-1000
Email address alexandra.stefanovic@duke.edu

I am convinced that caring for patients with malignant hematologic diseases requires not only up-to-date medical knowledge, but also an understanding of the individual patient's needs and circumstances. I encourage patients to take an active role in their treatment and recovery and I work with them to develop an individualized treatment plan that includes the most advanced therapies available today. My practice focuses primarily on disorders of the lymphatic system (Hodgkin and non-Hodgkin lymphoma and chronic lymphocytic leukemia). As an integral part of my clinical activities, I am dedicated to teaching young physicians at all levels of training and educating the next generation of hematologists.

Education and Training

  • Fellowship in Hematology/Oncology, Jackson Memorial Hospital, Miami, Florida, 2005 - 2008
  • Internal Medicine Residency, Western Pennsylvania Hospital, 2002 - 2005
  • M.D., University of Cologne (Germany, 1999

Publications

Kelly, KR, Friedberg, JW, Park, SI, McDonagh, K, Hayslip, J, Persky, D, Ruan, J, Puvvada, S, Rosen, P, Iyer, SP, Stefanovic, A, Bernstein, SH, Weitman, S, Karnad, A, Monohan, G, VanderWalde, A, Mena, R, Schmelz, M, Spier, C, Groshen, S, Venkatakrishnan, K, Zhou, X, Sheldon-Waniga, E, Leonard, EJ, and Mahadevan, D. "Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/Vincristine in Relapsed/Refractory Aggressive B-cell Lymphoma." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 24, no. 24 (December 2018): 6150-6159.

PMID
30082475
Full Text

Alderuccio, JP, Stefanovic, A, Dammrich, D, Chapman, JR, Vega, F, Selvaggi, G, Tzakis, A, and Lossos, IS. "Decreased survival in hepatitis C patients with monomorphic post-transplant lymphoproliferative disorder after liver transplantation treated with frontline immunochemotherapy." Leukemia & Lymphoma 59, no. 9 (September 2018): 2096-2104.

PMID
29252057
Full Text

Dejman, A, Alavi, SN, Thomas, DB, Stefanovic, A, Asif, A, and Nayer, A. "The potential role of complements in cocaine-induced thrombotic microangiopathy." Clinical kidney journal 11, no. 1 (February 2018): 26-28.

PMID
29423197
Full Text

Hosein, PJ, Sandoval-Sus, JD, Goodman, D, Arteaga, AG, Reis, I, Hoffman, J, Stefanovic, A, Rosenblatt, JD, and Lossos, IS. "Updated survival analysis of two sequential prospective trials of R-MACLO-IVAM followed by maintenance for newly diagnosed mantle cell lymphoma." American Journal of Hematology 90, no. 6 (June 2015): E111-E116.

PMID
25737247
Full Text

Lossos, IS, Fabregas, JC, Koru-Sengul, T, Miao, F, Goodman, D, Serafini, AN, Hosein, PJ, Stefanovic, A, Rosenblatt, JD, and Hoffman, JE. "Phase II study of (90)Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma." Leukemia & lymphoma 56, no. 6 (June 2015): 1750-1755.

PMID
25315074
Full Text

Fabregas, JC, Hoffman, JE, Koru-Sengul, T, Feng, M, Goodman, D, Serafini, A, Hosein, PJ, Stefanovic, A, Rosenblatt, JD, and Lossos, IS. "Phase II study of (90)y Ibritumomab Tiuxetan (Zevalin) in Patients with Previously Untreated Marginal Zone Lymphoma." December 6, 2014.

Scholars@Duke

Deutsch, YE, Dammrich, DJ, Fabregas, JC, Pirnentel, A, Stefanovic, A, and Hoffman, JE. "Clinical Experience Of Lenalidomide Plus Low Dose Dexamethasone As First-Line Therapy For Multiple Myeloma At a Large County Hospital Caring For An Indigent Population." November 15, 2013.

Scholars@Duke

Kelly, KR, Persky, DO, Mahadevan, D, Miller, TP, Puvvada, SD, McDonagh, K, Hayslip, J, Park, SI, Ruan, J, Rosen, PJ, Iyer, SP, Stefanovic, A, Zhang, B, Zhou, X, Ullmann, CD, Leonard, EJ, and Friedberg, JW. "Phase 1 Study Of Investigational Agent MLN8237 (Alisertib) plus Rituximab +/- Vincristine In Patients (Pts) With Relapsed/Refractory (Rel/Ref) Aggressive B-Cell Lymphomas." November 15, 2013.

Scholars@Duke

Sandoval-Sus, JD, Hosein, PJ, Goodman, D, Stefanovic, A, Rosenblatt, JD, and Lossos, IS. "Updated Analysis of a Prospective Phase II Trial of R-MACLO-IVAM Followed by Maintenance for Mantle Cell Lymphoma." November 16, 2012.

Scholars@Duke

Talebi, TN, Stefanovic, A, Merchan, J, Lian, E, and Silva, O. "Sunitinib-induced microangiopathic hemolytic anemia with fatal outcome." American Journal of Therapeutics 19, no. 4 (July 2012): e143-e145.

PMID
21403468
Full Text

Pages